Susceptibility of HPV16 and 18 to high level disinfectants indicated for semi-critical ultrasound probes

Journal of Medical Virology

Volumn 88, Issue 6, 2016, Pages 1076-1080

  Ryndock, Eric ^a   Robison, Richard ^b   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

High level disinfection (HLD); ortho phthalaldehyde; Trophon EPR; Virucidal

Indexed keywords

DISINFECTANT AGENT; GLUTARALDEHYDE; HYDROGEN PEROXIDE; HYPOCHLORITE; HYPOCHLOROUS ACID;

ARTICLE; AUTOMATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DISINFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; KERATINOCYTE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; CELL CULTURE; CELL LINE; DEVICES; DRUG EFFECTS; ECHOGRAPHY; EPITHELIUM CELL; GENETICS; PROCEDURES; VIROLOGY;

CELL LINE; CELLS, CULTURED; DISINFECTANTS; DISINFECTION; EPITHELIAL CELLS; GLUTARAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; KERATINOCYTES; ULTRASONOGRAPHY; VIRION;

EID: 84962034521     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24421     Document Type: Article

References (22)

1. ASTM International. 2011. ASTM E1053-11 Standard Test Method to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces.
2. Biryukov J, Cruz L, Ryndock EJ, Meyers C. 2014. Native human papillomavirus production, quantification, and infectivity analysis. Methods Mol Biol 1249:317-331.
3. Broker T, Botchan M. 1986. Papillomaviruses: retrospectives and prospectives. Cancer Cells 4:17-36.
4. Casalegno JS, Le Bail Carval K, Eibach D, Valdeyron ML, Lamblin G, Jacquemoud H, Mellier G, Lina B, Gaucherand P, Mathevet P, Mekki Y. 2012. High risk HPV contamination of endocavity vaginal ultrasound probes: an underestimated route of nosocomial infection? PLoS ONE 7:e48137.
5. Centers for Disease Control (CDC). 2008. Guideline for Disinfection and Sterilization in Healthcare Facilities. CDC.
6. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. 2008. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612-619.
7. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. 2011. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294-4301.
8. Federal Drug Administration. 2000. Guidance for Industry and FDA Reviewers: Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/High Level Disinfectants.
9. Feldman MY. 1973. Reactions of nucleic acids and nucleoproteins with formaldehyde. Prog Nucleic Acid Res Mol Biol 13:1-49.
10. Fisher CW, Fiorello A, Shaffer D, Jackson M, McDonnell GE. 2012. Aldehyde-resistant mycobacteria bacteria associated with the use of endoscope reprocessing systems. Am J Infect Control 40:880-882.
11. Howley PM. 1990. Papillomavirinae and their replication. In: Fields BN, Knipe DM, Chanock RMea, editors. Fields Virology. New York: Raven Press, pp 1625-1650.
12. M'Zali F, Bounizra C, Leroy S, Mekki Y, Quentin-Noury C, Kann M. 2014. Persistence of microbial contamination on transvaginal ultrasound probes despite low-level disinfection procedure. PLoS ONE 9:e93368.
13. Ma ST, Yeung AC, Chan PK, Graham CA. 2013. Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department. Emerg Med J 30:472-475.
14. McDonnell G, Burke P. 2011. Disinfection: is it time to reconsider Spaulding? J Hosp Infect 78:163-170.
15. Meyers J, Ryndock E, Conway MJ, Meyers C, Robison R. 2014. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother 69:1546-1550.
16. Pfister H. 1987a. Human papillomaviruses and genital cancer. Adv Cancer Res 48:113-147.
17. Pfister H. 1987b. Relationship of papillomaviruses to anogenital cancer. Obstet Gynecol Clin North Am 14:349-361.
18. Ryndock EJ, Conway MJ, Alam S, Gul S, Murad S, Christensen ND, Meyers C. 2014. Roles for human papillomavirus type 16 l1 cysteine residues 161, 229, and 379 in genome encapsidation and capsid stability. PLoS ONE 9:e99488.
19. Rutala WA, Weber DJ, HICPAC. 2008. Guideline for Disinfection and Sterilization in Healthcare Facilities. USA: Centers for Disease Control.
20. Taichman LP, LaPorta RF. 1986. The expression of papillomaviruses in epithelial cells. In: Salzman N, Howley PM, editors. The Papillomaviruses. New York: Plenum Press, pp 109-139.
21. U.S. Department of Health And Human Services FDA, Center for Devices and Radiological Health, Infection Control Devices Branch, Division of Dental, Infection Control and General Hospital Devices, Office of Device Evaluation. 2000. Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/High Level Disinfectants.
22. zur Hausen H, Schneider A. 1987. The role of papillomaviruses in human anogenital cancer. In: Salzman N, Howley PM, editors. The Papillomaviruses. New York: Plenum Press, pp 245-263.